Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 4
2006 7
2007 3
2008 1
2010 3
2011 6
2012 5
2013 1
2014 4
2015 8
2016 7
2017 3
2018 6
2019 4
2020 3
2021 9
2022 11
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Diffusion weighted imaging with reverse encoding distortion correction: Improvement of image quality and distortion for accurate ADC evaluation in in vitro and in vivo studies.
Furuta M, Ikeda H, Hanamatsu S, Yamamoto K, Shinohara M, Ikedo M, Yui M, Nagata H, Nomura M, Ueda T, Ozawa Y, Toyama H, Ohno Y. Furuta M, et al. Among authors: yamamoto k. Eur J Radiol. 2024 Feb;171:111289. doi: 10.1016/j.ejrad.2024.111289. Epub 2024 Jan 6. Eur J Radiol. 2024. PMID: 38237523
Deep Learning Reconstruction to Improve the Quality of MR Imaging: Evaluating the Best Sequence for T-category Assessment in Non-small Cell Lung Cancer Patients.
Takenaka D, Ozawa Y, Yamamoto K, Shinohara M, Ikedo M, Yui M, Oshima Y, Hamabuchi N, Nagata H, Ueda T, Ikeda H, Iwase A, Yoshikawa T, Toyama H, Ohno Y. Takenaka D, et al. Among authors: yamamoto k. Magn Reson Med Sci. 2023 Sep 1. doi: 10.2463/mrms.mp.2023-0068. Online ahead of print. Magn Reson Med Sci. 2023. PMID: 37661425 Free article.
Pulmonary MRI with ultra-short TE using single- and dual-echo methods: comparison of capability for quantitative differentiation of non- or minimally invasive adenocarcinomas from other lung cancers with that of standard-dose thin-section CT.
Ohno Y, Yui M, Yamamoto K, Ikedo M, Oshima Y, Hamabuchi N, Hanamatsu S, Nagata H, Ueda T, Ikeda H, Takenaka D, Yoshikawa T, Ozawa Y, Toyama H. Ohno Y, et al. Among authors: yamamoto k. Eur Radiol. 2024 Feb;34(2):1065-1076. doi: 10.1007/s00330-023-10105-4. Epub 2023 Aug 15. Eur Radiol. 2024. PMID: 37580601
Deep learning reconstruction for brain diffusion-weighted imaging: efficacy for image quality improvement, apparent diffusion coefficient assessment, and intravoxel incoherent motion evaluation in in vitro and in vivo studies.
Hanamatsu S, Murayama K, Ohno Y, Yamamoto K, Yui M, Toyama H. Hanamatsu S, et al. Among authors: yamamoto k. Diagn Interv Radiol. 2023 Sep 5;29(5):664-673. doi: 10.4274/dir.2023.232149. Epub 2023 Aug 9. Diagn Interv Radiol. 2023. PMID: 37554957 Free PMC article.
Three-Dimensional Gradient-Echo-Based Amide Proton Transfer-Weighted Imaging of Brain Tumors: Comparison With Two-Dimensional Spin-Echo-Based Amide Proton Transfer-Weighted Imaging.
Murayama K, Ohno Y, Yui M, Yamamoto K, Ikedo M, Ohba S, Hanamatsu S, Iwase A, Ikeda H, Hirose Y, Toyama H. Murayama K, et al. Among authors: yamamoto k. J Comput Assist Tomogr. 2023 May-Jun 01;47(3):494-499. doi: 10.1097/RCT.0000000000001432. Epub 2023 Feb 10. J Comput Assist Tomogr. 2023. PMID: 37185016
Reverse encoding distortion correction for diffusion-weighted MRI: Efficacy for improving image quality and ADC evaluation for differentiating malignant from benign areas in suspected prostatic cancer patients.
Ueda T, Ohno Y, Shinohara M, Yamamoto K, Ikedo M, Yui M, Yoshikawa T, Takenaka D, Ishida S, Furuta M, Matsuyama T, Nagata H, Ikeda H, Ozawa Y, Toyama H. Ueda T, et al. Among authors: yamamoto k. Eur J Radiol. 2023 May;162:110764. doi: 10.1016/j.ejrad.2023.110764. Epub 2023 Mar 5. Eur J Radiol. 2023. PMID: 36905716
Healing rate of macular edema secondary to branch retinal vein occlusion in two years after initiation of intravitreal ranibizumab later combined with other treatment as needed and characteristics of refractory cases.
Kawakami S, Wakabayashi Y, Watanabe Y, Umazume K, Yamamoto K, Goto H. Kawakami S, et al. Among authors: yamamoto k. PLoS One. 2023 Jan 3;18(1):e0278968. doi: 10.1371/journal.pone.0278968. eCollection 2023. PLoS One. 2023. PMID: 36595494 Free PMC article.
90 results